According to Gram Research analysis, a 2026 study of 68 psoriatic arthritis patients found that those with higher vitamin D levels actually had lower bone density in the lower spine compared to those with lower vitamin D levels, suggesting vitamin D’s effect on bone health in this autoimmune disease is more complex than in the general population. Most other bone health markers showed no significant differences between groups, indicating that inflammation from the disease itself may play a larger role in bone problems than vitamin D status alone.

Psoriatic arthritis is an autoimmune disease that damages joints and bones, sometimes leading to weak bones called osteoporosis. Vitamin D is known to help keep bones strong, but scientists weren’t sure how it affects people with psoriatic arthritis specifically. Gram Research analysis of a new study looked at 68 patients with this condition to see if vitamin D levels made a difference in their bone density and bone health markers. The researchers found some surprising results about how vitamin D relates to bone strength in these patients, though they say more research is needed to fully understand what it means for treatment.

Key Statistics

A 2026 cross-sectional study of 68 psoriatic arthritis patients found that those with vitamin D levels above 75 nmol/L had significantly lower bone mineral density in the lumbar spine compared to those with lower vitamin D levels, contrary to typical expectations.

In the same 68-patient study, researchers found no significant differences in trabecular bone score, alkaline phosphatase, or most bone turnover markers between patients with high and low vitamin D levels, suggesting vitamin D status alone may not be the primary driver of bone problems in psoriatic arthritis.

The 2026 research on 68 psoriatic arthritis patients revealed that bone metabolism in this autoimmune disease responds differently to vitamin D than in the general population, highlighting the need for personalized bone health strategies beyond standard vitamin D supplementation.

The Quick Take

  • What they studied: Whether vitamin D levels affect bone density and bone health in people with psoriatic arthritis, an autoimmune disease that causes joint inflammation and bone problems.
  • Who participated: 68 patients who had been diagnosed with psoriatic arthritis. Researchers divided them into two groups based on their vitamin D levels: those with higher levels (above 75 nmol/L) and those with lower levels (at or below 75 nmol/L).
  • Key finding: Patients with higher vitamin D levels actually had lower bone density in their lower spine compared to those with lower vitamin D levels. This was unexpected and suggests vitamin D’s effect on bone health in psoriatic arthritis may be more complicated than previously thought.
  • What it means for you: If you have psoriatic arthritis, simply taking more vitamin D supplements may not automatically strengthen your bones the way it does for people without this condition. Talk to your doctor about your specific bone health needs, as this disease affects bone metabolism differently than in the general population.

The Research Details

This was a cross-sectional study, which means researchers took a snapshot in time of 68 patients with psoriatic arthritis and measured their vitamin D levels and bone health at the same moment. They split the patients into two groups based on whether their vitamin D levels were above or below 75 nmol/L, which is a standard measurement used by doctors. The researchers then used a special X-ray machine called a DXA scanner to measure how dense the bones were at different locations in the body, particularly the lower spine and hip. They also took blood samples to check various markers that show how quickly bones are breaking down and rebuilding, including calcium, phosphorus, and special proteins that indicate bone turnover.

This research approach is important because it helps doctors understand what’s actually happening with bones in real patients with psoriatic arthritis. Rather than studying bones in a lab, the researchers looked at real people living with this condition. By comparing patients with different vitamin D levels, they could see if vitamin D status was connected to bone health problems. This type of study is useful for identifying patterns and relationships that might guide future treatment decisions.

This study has some strengths and some limitations to keep in mind. The strength is that it used precise medical equipment (DXA scanning) to measure bone density, which is accurate and reliable. However, the study only included 68 patients, which is a relatively small group. The researchers themselves noted that larger studies are needed to confirm their findings. Because this is a cross-sectional study, it shows relationships between vitamin D and bone health at one point in time, but it cannot prove that vitamin D causes these bone changes. The study also doesn’t tell us whether vitamin D supplementation would actually improve bone health in these patients.

What the Results Show

The main finding was unexpected: patients with higher vitamin D levels (above 75 nmol/L) had significantly lower bone mineral density in their lower spine compared to patients with lower vitamin D levels. This goes against what many people would expect, since vitamin D is known to help build strong bones in healthy people. However, the researchers found no significant differences between the two groups in other bone measurements, including a score that measures bone quality and structure, or in most of the blood markers that show how quickly bones are breaking down and rebuilding. The only bone turnover marker that showed differences was CTX-I, which indicates bone breakdown, though the pattern was complex. This suggests that vitamin D’s relationship with bone health in psoriatic arthritis is more complicated than in people without this autoimmune disease.

Several other measurements showed no significant differences between the high and low vitamin D groups. These included alkaline phosphatase (an enzyme related to bone building), osteocalcin (a protein made by bone-building cells), parathyroid hormone levels, and the trabecular bone score, which measures the internal structure and quality of bones. The fact that most of these markers didn’t differ suggests that vitamin D status alone may not be the main driver of bone problems in psoriatic arthritis. This indicates that other factors related to the autoimmune disease itself, such as inflammation, may play a larger role in bone health for these patients.

Previous research has shown that vitamin D is crucial for bone health in the general population and helps prevent osteoporosis. However, this study suggests that the relationship between vitamin D and bone health may work differently in people with psoriatic arthritis. The autoimmune inflammation in this condition appears to disrupt normal bone metabolism in ways that vitamin D alone cannot fully address. This finding aligns with growing recognition that autoimmune diseases like psoriatic arthritis create unique bone health challenges that don’t always respond to standard bone health interventions the same way they do in people without these conditions.

This study has several important limitations. First, it only included 68 patients, which is a small sample size. Larger studies with hundreds or thousands of patients would give more reliable results. Second, because it’s a cross-sectional study, it only shows a snapshot in time and cannot prove that vitamin D causes the bone density differences observed. Third, the study doesn’t tell us whether giving vitamin D supplements to patients with low levels would actually improve their bone health. Fourth, the researchers didn’t measure inflammation levels or disease activity, which might explain some of the bone health differences. Finally, the study was conducted in one location and may not represent all people with psoriatic arthritis, who may have different genetics, diets, or disease patterns.

The Bottom Line

If you have psoriatic arthritis, work with your rheumatologist to monitor your bone health regularly through bone density scans. Don’t assume that taking vitamin D supplements alone will protect your bones, as this condition affects bone metabolism differently than in people without autoimmune disease. Your doctor may recommend vitamin D supplementation as part of a broader bone health strategy that also addresses inflammation and may include other medications or lifestyle changes. The evidence from this study is moderate in strength, so recommendations should be personalized to your specific situation.

This research is most relevant for people who have been diagnosed with psoriatic arthritis and are concerned about bone health and osteoporosis. It’s also important for rheumatologists and other doctors who treat psoriatic arthritis patients. People with other autoimmune diseases affecting bones may find this information relevant, though the findings are specific to psoriatic arthritis. People without autoimmune diseases should not assume these findings apply to them, as vitamin D’s role in bone health appears to be different in the general population.

Bone health changes happen slowly over months and years. If you start vitamin D supplementation or other bone health interventions, you typically won’t see significant improvements in bone density for at least 6 to 12 months. Most doctors recommend repeat bone density scans every 1 to 2 years to track changes over time. Because psoriatic arthritis affects bone metabolism in complex ways, improvements may be slower or less dramatic than in people without this condition.

Frequently Asked Questions

Does vitamin D supplementation help prevent bone loss in psoriatic arthritis?

A 2026 study of 68 psoriatic arthritis patients suggests vitamin D’s effect on bone health in this condition is more complex than expected. Higher vitamin D levels were associated with lower spine bone density, indicating that supplementation alone may not prevent bone loss. Work with your rheumatologist to develop a comprehensive bone health strategy.

What vitamin D level should I aim for if I have psoriatic arthritis?

This study divided patients at 75 nmol/L, but the findings suggest that simply achieving higher vitamin D levels may not automatically protect bones in psoriatic arthritis. Your doctor should help determine your target vitamin D level based on your individual disease activity, inflammation levels, and overall bone health status rather than a one-size-fits-all number.

How often should I get bone density scans if I have psoriatic arthritis?

Most doctors recommend bone density scans every 1 to 2 years for people with psoriatic arthritis, as this condition increases osteoporosis risk. Your rheumatologist may recommend more frequent scans depending on your disease severity, age, and other risk factors for bone loss.

Is vitamin D the most important factor for bone health in psoriatic arthritis?

According to the 2026 research, vitamin D status alone may not be the primary factor affecting bone health in psoriatic arthritis. The autoimmune inflammation and disease activity appear to play a larger role in bone metabolism, suggesting a comprehensive approach addressing inflammation is essential alongside vitamin D management.

Can I rely on vitamin D supplements to prevent osteoporosis with psoriatic arthritis?

No, vitamin D supplementation alone is not sufficient for preventing osteoporosis in psoriatic arthritis. This 2026 study suggests bone health in this condition requires a multifaceted approach including disease control, inflammation management, and possibly other medications, in addition to appropriate vitamin D levels.

Want to Apply This Research?

  • Track your vitamin D supplement intake (dose and frequency) alongside any bone-related symptoms like joint pain or stiffness. Record the dates of any bone density scans (DXA results) and note the specific measurements for lumbar spine, hip, and total body. Include any changes in disease activity or inflammation levels, as these may affect bone health.
  • If your doctor recommends vitamin D supplementation, set up a daily reminder to take your supplement at the same time each day. Log your intake in the app to maintain consistency. Also track any dietary sources of vitamin D (fatty fish, fortified milk, egg yolks) and note your sun exposure, as these contribute to your total vitamin D intake.
  • Create a quarterly check-in to review your vitamin D levels and any bone-related symptoms. Set reminders for scheduled bone density scans (typically every 1 to 2 years). Track trends in your supplement adherence and correlate them with any changes in joint symptoms or bone health markers reported by your doctor. Share this data with your rheumatologist at each visit to inform treatment decisions.

This article summarizes research findings and is not a substitute for professional medical advice. Psoriatic arthritis is a complex autoimmune disease that requires individualized treatment from a qualified rheumatologist. Do not start, stop, or change any vitamin D supplementation or other treatments without consulting your doctor first. Bone health management in psoriatic arthritis requires a comprehensive approach that may include medications, lifestyle changes, and regular monitoring. The findings from this study are preliminary and based on a small sample size. Always discuss your specific bone health concerns and vitamin D status with your healthcare provider, who can recommend appropriate testing and treatment based on your individual circumstances.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Vitamin D and bone health in psoriatic arthritis: bone mineral density, turnover markers, and biochemical measures. , Wiener medizinische Wochenschrift (1946) (2026). PubMed 42789164 | DOI
Topics
psoriatic arthritis vitamin D bone health bone mineral density osteoporosis autoimmune disease bone turnover markers DXA scan